SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein | 21-811

SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein | 21-811 | Gentaur UK, US & Europe Distribution

Tested Application: N/A

Application: N/A

Tpredicted Molecular Weight: ~35kDa (SDS-PAGE)

Physical State: Lyophilized

Buffer: Lyophilized. Contains PBS.

Storage Condition: Short Term StorageL: +4°C, Long Term Storage: -20°C, Handling Advice: After opening, prepare aliquots and store at -20°C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. For maximum product recovery after thawing, centrifuge the vial before opening the cap. Use/Stability: Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.

Alternate Name: 2019-nCoV Spike Protein S1 (RBD); Spike Receptor Binding Domain, 501Y.V1

Background: N/A

Shipping: N/A

Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.

Source: HEK293 cells

Species: Human

By Source: Human Cells

By Species: Human

Fusion Tag: N/A

Sequence: Receptor-binding domain (RBD) of SARS-CoV-2 Spike protein S1 (aa 319-541) containing the mutation N501Y is fused at the C-terminus to a His-tag.

Bological Activity: Binds to anti-SARS-CoV-2 Spike (RBD) antibodies in serum or plasma. Binds to human ACE2.

Purity: ≥95% (SDS-PAGE)